Invirion Diagnostics, LLC Launches First Quantitative HPV E6, E7 Assay and Announces CE Mark and Approval for Reimbursement in Spain

OAK BROOK, Ill.--(BUSINESS WIRE)--Invirion Diagnostics, LLC announced today that its highly sensitive HPV screening test HPV OncoTect™ received approval for reimbursement from two of Spain’s largest insurance payors - Sanitas and Aresa. Distributed by Labec Pharma located in Madrid, HPV OncoTect™ is CE marked and available throughout Spain and Portugal.

MORE ON THIS TOPIC